| UniProt ID | EAA2_HUMAN | |
|---|---|---|
| UniProt AC | P43004 | |
| Protein Name | Excitatory amino acid transporter 2 | |
| Gene Name | SLC1A2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 574 | |
| Subcellular Localization |
Cell membrane Multi-pass membrane protein . |
|
| Protein Description | Sodium-dependent, high-affinity amino acid transporter that mediates the uptake of L-glutamate and also L-aspartate and D-aspartate. [PubMed: 7521911] | |
| Protein Sequence | MASTEGANNMPKQVEVRMHDSHLGSEEPKHRHLGLRLCDKLGKNLLLTLTVFGVILGAVCGGLLRLASPIHPDVVMLIAFPGDILMRMLKMLILPLIISSLITGLSGLDAKASGRLGTRAMVYYMSTTIIAAVLGVILVLAIHPGNPKLKKQLGPGKKNDEVSSLDAFLDLIRNLFPENLVQACFQQIQTVTKKVLVAPPPDEEANATSAVVSLLNETVTEVPEETKMVIKKGLEFKDGMNVLGLIGFFIAFGIAMGKMGDQAKLMVDFFNILNEIVMKLVIMIMWYSPLGIACLICGKIIAIKDLEVVARQLGMYMVTVIIGLIIHGGIFLPLIYFVVTRKNPFSFFAGIFQAWITALGTASSAGTLPVTFRCLEENLGIDKRVTRFVLPVGATINMDGTALYEAVAAIFIAQMNGVVLDGGQIVTVSLTATLASVGAASIPSAGLVTMLLILTAVGLPTEDISLLVAVDWLLDRMRTSVNVVGDSFGAGIVYHLSKSELDTIDSQHRVHEDIEMTKTQSIYDDMKNHRESNSNQCVYAAHNSVIVDECKVTLAANGKSADCSVEEEPWKREK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 3 | Phosphorylation | -----MASTEGANNM -----CCCCCCCCCC | 26.20 | 29083192 | |
| 4 | Phosphorylation | ----MASTEGANNMP ----CCCCCCCCCCC | 28.97 | 29083192 | |
| 21 | Phosphorylation | VEVRMHDSHLGSEEP EEEEECCCCCCCCCC | 13.11 | 15822905 | |
| 25 | Phosphorylation | MHDSHLGSEEPKHRH ECCCCCCCCCCCCCC | 45.18 | 25332170 | |
| 38 | S-palmitoylation | RHLGLRLCDKLGKNL CCHHHHHHHHHCCHH | 3.33 | - | |
| 99 | Phosphorylation | LILPLIISSLITGLS HHHHHHHHHHHHHCC | 16.46 | 22817900 | |
| 100 | Phosphorylation | ILPLIISSLITGLSG HHHHHHHHHHHHCCC | 17.24 | 22817900 | |
| 103 | Phosphorylation | LIISSLITGLSGLDA HHHHHHHHHCCCCCH | 37.05 | 23879269 | |
| 123 | Phosphorylation | LGTRAMVYYMSTTII CCHHHHHHHHHHHHH | 4.75 | - | |
| 124 | Phosphorylation | GTRAMVYYMSTTIIA CHHHHHHHHHHHHHH | 3.53 | - | |
| 206 | N-linked_Glycosylation | PPPDEEANATSAVVS CCCCHHCCHHHHHHH | 47.21 | UniProtKB CARBOHYD | |
| 216 | N-linked_Glycosylation | SAVVSLLNETVTEVP HHHHHHHHCCCCCCC | 48.46 | UniProtKB CARBOHYD | |
| 494 | Phosphorylation | SFGAGIVYHLSKSEL CCCCCHHEEECHHHH | 8.63 | 21082442 | |
| 506 | Phosphorylation | SELDTIDSQHRVHED HHHCCCHHCCCHHHH | 24.84 | - | |
| 521 | Phosphorylation | IEMTKTQSIYDDMKN HHHHHHHHHHHHHHH | 28.48 | 24076635 | |
| 523 | Phosphorylation | MTKTQSIYDDMKNHR HHHHHHHHHHHHHHH | 15.90 | 25884760 | |
| 532 | Phosphorylation | DMKNHRESNSNQCVY HHHHHHHCCCCCCEE | 45.58 | 25332170 | |
| 534 | Phosphorylation | KNHRESNSNQCVYAA HHHHHCCCCCCEEEE | 37.24 | 25332170 | |
| 539 | Phosphorylation | SNSNQCVYAAHNSVI CCCCCCEEEECCEEE | 13.00 | 25332170 | |
| 544 | Phosphorylation | CVYAAHNSVIVDECK CEEEECCEEEEEECE | 11.89 | - | |
| 560 | Phosphorylation | TLAANGKSADCSVEE EEEECCCCCCCCCCC | 30.64 | - | |
| 564 | Phosphorylation | NGKSADCSVEEEPWK CCCCCCCCCCCCCCC | 32.86 | 24076635 | |
| 571 | Sumoylation | SVEEEPWKREK---- CCCCCCCCCCC---- | 62.49 | - | |
| 571 | Sumoylation | SVEEEPWKREK---- CCCCCCCCCCC---- | 62.49 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of EAA2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 38 | C | Palmitoylation |
| - |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of EAA2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| AJUBA_HUMAN | AJUBA | physical | 11860269 | |
| PML_HUMAN | PML | physical | 17823119 | |
| TAU_HUMAN | MAPT | physical | 19527721 | |
| RL17_HUMAN | RPL17 | physical | 26344197 | |
| RL23A_HUMAN | RPL23A | physical | 26344197 | |
| RL32_HUMAN | RPL32 | physical | 26344197 | |
| RL38_HUMAN | RPL38 | physical | 26344197 | |
| RL5_HUMAN | RPL5 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Phosphoproteomic analysis of synaptosomes from human cerebralcortex."; DeGiorgis J.A., Jaffe H., Moreira J.E., Carlotti C.G. Jr., Leite J.P.,Pant H.C., Dosemeci A.; J. Proteome Res. 4:306-315(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21, AND MASSSPECTROMETRY. | |